Melogliptin, also known as EMD-675992 and GRC-8200, is a potent and selective a dipeptidyl peptidase IV (DPP-IV) inhibitor potentially for treatment of type II diabetes. Melogliptin significantly reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.75 percent in patients receiving 50mg twice daily dose and 0.60 percent in patients receiving 100 mg once daily dose.
Molecular Weight:
320.37
CAS Number:
[868771-57-7]
Formula:
C15H21FN6O
Target:
Others
T68491
* VAT and and shipping costs not included. Errors and price changes excepted